Skip to content

Safety and efficacy of Vitamin D3 supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial.

Randomized controlled trial · BMJ Open · 2023. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 37643857

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Safety and efficacy of Vitamin D3 supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial.

Bandyopadhyay A, Palepu S, Dhamija P et al.
BMJ Open · 2023

PubMed ID
37643857
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.